The American Biotechnology Exhibition (BIO International Convention, abbreviated as BIO) was founded in 1993 and is the annual conference of the Global Biotechnology Innovation Organization; it is also the largest, most professional, and most influential biotechnology event worldwide. BIO aims to promote the global biotechnology industry by supporting biotechnology projects and initiatives; the profits from the biotechnology international conference are returned to the biotechnology industry.

The American Biotechnology Exhibition (BIO) does not primarily aim for trade transactions but focuses more on a model that combines exhibitions with conferences; providing a platform for promotion and display for companies, science parks, and research institutions from various countries. It also organizes professional forums, press conferences, exchange meetings, matchmaking negotiations, and other activities to provide an integrated platform for information exchange, technology cooperation, and risk investment financing for exhibitors and participants.

The American Biotechnology Exhibition (BIO) also provides training for drug development, business operations, contract management, financing, legal issues, and recruitment services for professionals in the biotechnology industry. By expanding the functions of the exhibition, it has largely moved away from the traditional model centered on trade, becoming an undisputed leader in the global biotechnology field. BIO is committed to creating a policy environment that enables the industry to continue to realize its vision of improving the world through biotechnological innovation. (The content of this article is the property of Juzhan Network and may not be forwarded without permission.)